Harbin Pharmaceutical Group Co., Ltd. Class ASSE: 600664

"Harbin Pharmaceutical Group Co., Ltd."Announcement on the Proposed Selection in the 12th Batch of National Centralized Drug Procurement

Aug 4, 2026 · Issued by Harbin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on the Proposed Selection in the 12th Batch of National Centralized Drug Procurement

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Harbin Pharmaceutical Group Co., Ltd. Class A

"Harbin Pharmaceutical Group Co., Ltd."Announcement on the Affiliated Enterprise's Receipt of the Approval Notice for the Marketing Application of a Chemical APIJul 30
"Harbin Pharmaceutical Group Co., Ltd."Announcement on Severe Abnormal Fluctuations in Stock Trading and Risk WarningJul 24
"Harbin Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 27th Meeting of the 10th Board of DirectorsJul 17
"Harbin Pharmaceutical Group Co., Ltd."Announcement on Adjustment to the Company's Products in the National Essential Medicines ListJul 14

All Harbin Pharmaceutical Group Co., Ltd. Class A news releases